ID

11182

Description

Z1041: Study Drug Completion - FEC-75/Paclitaxel (SDCFP) NCT00513292 Combination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With Palpable Breast Cancer That Can Be Removed by Surgery Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=20FE4AE7-E041-0F11-E044-0003BA3F9857

Link

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=20FE4AE7-E041-0F11-E044-0003BA3F9857

Keywords

  1. 8/26/12 8/26/12 -
  2. 1/9/15 1/9/15 - Martin Dugas
  3. 6/21/15 6/21/15 -
Uploaded on

June 21, 2015

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0 Legacy

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Z1041: Study Drug Completion - FEC-75/Paclitaxel (SDCFP) NCT00513292

No Instruction available.

  1. StudyEvent: Z1041: Study Drug Completion - FEC-75/Paclitaxel (SDCFP)
    1. No Instruction available.
Header Module
Visit
Assessment of Chemotherapy
Agent name (FEC-75 was given, complete:)
Agent name (FEC-75 was given, complete:)
Were there any dose modifications or additions/omissions to protocol treatment?
Dose Modification Reason (If yes, )

Similar models

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial